Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live

Cantor Fitzgerald & ADMA Biologics

1 shared events · Importance 3 · Last updated Jun 15, 2026

Importance
3
Shared Events
1
Actions
1
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
63
Regulatory
Cantor Fitzgerald: Cantor Fitzgerald downgraded ADMA Biologics' stock, citing disappointment with the company's response to the Culper Research report, further contributing to the stock's decline.
ADMA Biologics: ADMA Biologics is the primary subject of the class action lawsuits and investigations due to allegations of channel stuffing, undisclosed related-party transactions, and misleading revenue growth, which caused its stock price to decline significantly.
Apr 01, 2026 · 301 articles
NEWSDESK
Explore this relationship live

Track how Cantor Fitzgerald and ADMA Biologics interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.